drugset / Trial / NCT06901297
The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Multicenter double-blind placebo-controlled randomized in parallel groups clinical trial of the efficacy and safety of Raphamin in the treatment of acute rhinosinusitis in adult patients.
Timeline
- Start
- 2025-04-03
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Raphamin | Unknown | 1 unknown | Oral |